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This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).SUMMARYThe intrinsic regenerative capacity of human fetal cardiac mesenchymal stromal cells (MSCs) has not been fully characterized. Here we
demonstrate that we can expand cells with characteristics of cardiovascular progenitor cells from the MSC population of human fetal
hearts. Cells cultured on cardiac muscle laminin (LN)-based substrata in combination with stimulation of the canonical Wnt/b-catenin
pathway showed increased gene expression of ISL1, OCT4, KDR, and NKX2.5. The majority of cells stained positive for PDGFR-a, ISL1,
and NKX2.5, and subpopulations also expressed the progenitor markers TBX18, KDR, c-KIT, and SSEA-1. Upon culture of the cardiac
MSCs in differentiation media and on relevant LNs, portions of the cells differentiated into spontaneously beating cardiomyocytes,
and endothelial and smoothmuscle-like cells. Our protocol for large-scale culture of human fetal cardiacMSCs enables future exploration
of the regenerative functions of these cells in the context of myocardial injury in vitro and in vivo.INTRODUCTION
In the developing heart, lineage-tracing experiments in
chicks and mice have revealed that the heart mainly de-
velops from mesenchymal progenitors of the first and sec-
ond heart fields (FHF and SHF, respectively) (Buckingham
et al., 2005; Kelly et al., 2014). The cells of the FHF are
defined by their co-expression of hyperpolarization-acti-
vated cyclic nucleotide-gated channel 4 (HCN4), TBX5 as
well as NKX2.5 (Buckingham et al., 2005; Spater et al.,
2014). The mesenchymal progenitors of the SHF originate
from the pharyngeal mesoderm and are characterized by
their expression of the LIM-homeodomain transcription
factor transcription factor Islet-1 (ISL1; Cai et al., 2003;
Laugwitz et al., 2005). The progenitors of the SHF mainly
contribute to the atria, the outflow tract (OFT), and the
right ventricle, whereas the FHF progenitors are involved
in the development of the left ventricle (Cai et al., 2003;StemMoretti et al., 2006; Genead et al., 2010; Laugwitz et al.,
2005; Laugwitz et al., 2008; Lam et al., 2009; Yang et al.,
2013). Apart from these two major cell sources of the FHF
and SHF, the cardiogenic mesoderm also seems to contain
a progenitor subpopulation, defined by its expression of
TBX18, which contributes to the sinus venosus myocar-
dium (Mommersteeg et al., 2010; Christoffels et al.,
2006), while cardiac neural crest cells seem to be involved
in valve formation and parasympathetic innervation, as
well as the septation of the OFT (Hildreth et al., 2008; Hut-
son and Kirby, 2007; Waldo et al., 2005).
Cardiac colony-forming unit fibroblasts with cardiovas-
cular progenitor properties have also been identified in
the fetal and adult hearts of mice and humans (Chong
et al., 2011, 2013). These cells demonstrate characteristics
of mesenchymal stromal cells (MSCs), express platelet-
derived growth factor receptor-alpha (PDGFR-a), and give
rise not only to epicardial cells but also to cells that occupyCell Reports j Vol. 6 j 607–617 j April 12, 2016 j ª2016 The Authors 607
the interstitial, perivascular, and adventitial niches of the
heart (Chong et al., 2011, 2013). MSCs in hearts of adult
mice have also been shown to express higher levels of spe-
cific transcription factors representing the FHF and SHF
than bone marrow MSCs (Pelekanos et al., 2012), which
might indicate organ-specific characteristics of the MSCs
persisting in the myocardium from the fetal stages to
adulthood. These findings collectively support the idea
that cardiac MSCs may be used as a source of cells with car-
diac progenitor characteristics.
We have explored the possibility of using the cardiac
MSCs of the human fetal heart for expansion of cells with
characteristics similar to those ofmesenchymal progenitors
that contribute to mammalian cardiogenesis. In this study
cardiac MSCs were reproducibly recovered from the
adherent cell fraction from first trimester human fetal
hearts by using defined culturing conditions, including
the use of specific laminin (LN) isoforms, in combination
with canonical Wnt/b-catenin stimulation. The MSCs ex-
pressed ISL1, PDGFR-a, andNKX2.5,where subpopulations
also expressed the stemness and potential cardiovascular
progenitor markers: kinase insert domain protein receptor
(KDR), the human orthologue of FLK1; c-KIT, the receptor
for the stem cell factor (Beltrami et al., 2003; (Bearzi et al.,
2007, 2009), stage-specific embryonic antigen 1 (SSEA-1)
(Blin et al., 2010), and TBX18 (Christoffels et al., 2006;
Mommersteeg et al., 2010). The fetal cardiac MSCs were
multipotent and could be differentiated into elongated,
striated, and spontaneously beating cardiomyocytes, endo-
thelial cells, and smoothmuscle cell-like cells, alsowhenus-
ing defined laminins as substrata. This implies that the
unique culturing conditions of human fetal cardiac MSCs
using a combination of canonical Wnt/b-catenin stimula-
tion and LN-based matrices facilitate the in vitro propaga-
tion of cells with cardiac progenitor characteristics.RESULTS
Enrichment and Expansion of Fetal Cardiac MSCs
In order to develop a culture protocol for successful propa-
gation of cardiac MSCs, the adherent cell fraction from
whole human fetal hearts (gestational weeks 6–10) was pre-
pared as previously described by Laugwitz et al. (2005). This
cell fraction contains a mixture of different cell types,
including the cardiac MSCs. To activate the transcriptional
network known to be involved in embryonic cardiogenesis
(Klaus et al., 2007), we focused on the canonicalWnt/b-cat-
enin signaling pathway, which has previously been shown
to be effective in expansion of SHF progenitors derived
from embryonic stem cells from mice and humans (Qyang
et al., 2007; Kwon et al., 2007; Moretti et al., 2006; Bu et al.,
2009) (Figure 1A).608 Stem Cell Reports j Vol. 6 j 607–617 j April 12, 2016 j ª2016 The AuthoBased on a strategy previously introduced by Qyang et al.
(2007), we used a Wnt3a-containing cell culture medium
(Wnt3a 100 ng/ml, see Experimental Procedures) to stimu-
late the canonical Wnt/b-catenin pathway. When cells of
the adherent cell fraction of human fetal hearts were
expanded on plastic, they multiplied rapidly (Figure 1B)
but showed a low expression of the cardiac progenitor
markers ISL1, KDR, andNKX2.5, as well as the pluripotency
marker OCT4 (Figure 1C).
In order to improve the culturing conditions, the
adherent cells were cultured on dishes pre-coated with
the Engelbreth-Holm Swarm mouse tumor-derived extra-
cellular matrix extract, Geltrex (GibcoBRL). This extract,
which contains basement membrane proteins such as
LN-111, has been widely used for culturing stem cells and
other cell types (Xu et al., 2001; Ludwig et al., 2006).
When the adherent cells were cultured on Geltrex in com-
bination with Wnt3a-containing medium, the cells
divided exponentially and were passaged every other day.
At 2 weeks, the adherent cells had expanded more than
1,000-fold (Figure 1B) and demonstrated activation of tran-
scription factors involved in defining cardiac progenitors
and multipotent stem cells (Figure 1C). Although cells
expanded on Geltrex, in combination with the presence
of Wnt3a, demonstrated increased gene-expression levels
of the pluripotency marker OCT4 in comparison with the
other culturing conditions, this expression was 103 times
lower than that found in pluripotent human embryonic
stem cells (Figure S1).
As expected for activation of the canonical Wnt/b-cate-
nin pathway, when using Wnt3a-containing medium in
combination with Geltrex, the cultured cells showed an
increased phosphorylation of S1490-Lrp6 and Dvl3 as
well as increased levels of active (dephosphorylated) b-cat-
enin compared with the cells of the initial adherent cell
fraction (Figure 1D). These data suggest that both the
Wnt3a-containing medium and Geltrex may provide
important signals for expansion of cells from the adherent
cell fraction of fetal human hearts, with transcriptional sig-
natures akin to those of cardiac progenitors (Moretti et al.,
2006).
Exclusion of either Wnt3a or Geltrex from the culture
protocol negatively affected proliferation of the cells in
the initial fraction (Figure 1B) and thereby preserved sur-
vival of the limited numbers of remaining endothelial cells
and cardiomyocytes among the adherent cells. This was
also reflected in a relatively high mRNA expression of
troponin T (TNNT2) under these culture conditions
(Figure 1C).
The cells were analyzed by flow cytometry using an MSC
antibody panel to confirm that the adherent cells
expanded for 2 weeks on Geltrex inWnt3a-containing me-
dium were derived from the fetal cardiac MSCs (Pittengerrs
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Figure 1. Derivation of Multipotent MSCs
from Human Fetal Hearts
(A) Schematic representation of the exper-
imental procedure used to generate and
expand multipotent cardiac MSCs from the
adherent cell fraction of human fetal hearts
(gestational weeks 6–10).
(B) The initial adherent MSC fraction was
cultured under different conditions: Wnt-
medium + Geltrex (green), Wnt-medium +
plastic (red), medium without Wnt3a +
Geltrex (blue), and medium without
Wnt3a + plastic (gray).
(C) mRNA expression levels of cardiogenic
genes in response to the different culture
conditions depicted in (B). Data are
normalized against the cells cultured with
Wnt3a + Geltrex and presented as mean ±
SD of three independent experiments per-
formed in quadruplicate. See also Figure S1.
(D) Western blot analysis confirmed the
activation of the Wnt/b-catenin pathway in
the cultured human fetal cardiac MSCs
(hfcMSC), demonstrating increased levels of
both phosphorylated S1490-Lrp6 and Dvl3
(left panel) as well as active (dephos-
phorylated) b-catenin (ABC) (right panel)
compared with the initial adherent cell
fraction. b-Actin was used as a control of
equal loading of protein.
**p < 0.01; ***p < 0.001.and Martin, 2004). With a purity of >85%, the cultured
adherent cells expressed MSC markers CD105, CD90,
CD73, and HLA-1, while being negative for HLA-DR and
the hematopoietic lineage markers CD14, CD11, CD80,
CD83, CD34, CD45, and endothelial marker CD31 (Fig-
ure S2). The cultured cells were also able to differentiate
in vitro into the three mesenchymal lineages, osteoblasts,
chondrocytes, and adipocytes (Figure 2), and thus fulfilled
the International Society of Cellular Therapy criteria for be-
ing MSCs (Horwitz et al., 2005). Cryopreservation had no
influence on the expression of the above-mentioned sur-
face markers or the ability to differentiate into the three
mesenchymal lineages.
Characterization of Cultured Cardiac MSCs
The gene-expression profile of the cardiac MSCs was
analyzed by microarray over time of culture, and we
focused on the core group of transcription factors known
to be important in regulation of cardiogenesis and espe-
cially the SHF development in mice (Black, 2007). The
gene-expression profile of the human fetal cardiac
MSCs showed only minor fluctuations over time in cul-
ture (from day 15 to day 48), including the expressionStemof mesodermal markers TBX6, TBX1/Brachyury, and
TBX18, together with the key transcription factors
involved in the transcriptional network of the SHF
(ISL1, GATA4, NKX2.5, FOXH1, FGF8), the FHF (TBX5,
NKX2.5), as well as other markers related to cardiovascu-
lar progenitors like PDGFR-a and the stemness markers
KDR, SSEA-1, and KIT (Figure 3A). The activated ISL1-
GATA4 pathway in the cultured cardiac MSCs correlated
well with the mRNA levels of cardiogenic bone morpho-
genic proteins (Cohen et al., 2007; Marvin et al., 2001)
and the concomitant expression of the early cardio-
myocyte markers NKX2.5 and mesoderm posterior 1
(MESP1). However, the cultured cardiac MSCs also express
mature cardiomyocyte markers such as myosin heavy
chain (MYH) 6 and 7, the endothelial marker VCAM1,
as well as the smooth muscle markers MYH11 and myo-
cardin (MYOCD).
Another important finding is that after 3 weeks in culture
(eight passages), the majority of the cardiac MSCs stained
positive for ISL1 (>90%) and also for NKX2.5 (>80%) (Fig-
ure 3B). CardiacMSCs staining positive for themesodermal
progenitor marker TBX18 were also sparsely identified
(Figure 3B).Cell Reports j Vol. 6 j 607–617 j April 12, 2016 j ª2016 The Authors 609
Figure 2. Differentiation into Mesenchymal Lineages
To confirm the mesenchymal origin of the fetal cardiac MSCs they
were differentiated into the three mesenchymal lineages: bone
(alkaline phosphatase, ALP), cartilage (Aggrecan), and adipose
tissue (oil red O, ORO). See also Figure S2. Scale bars represent
100 mm.Flow cytometry (Figure 3D) and immunofluorescence
(Figure 3C) analyses of the cultured cardiac MSCs derived
from 8- to 9-week human fetal hearts identified subpopula-
tions of cells that express the cell stemness markers KDR,
c-KIT, or SSEA-1, with low variability between cultures.
Moreover, immunofluorescence staining showed that the
majority of the cardiac MSCs expressed PDGFR-a.
Accordingly, the gene-expression profiles in combina-
tion with the immunohistochemical and flow cytometry
analyses demonstrate that the culture protocol utilized in
this study reproducibly allows for large-scale expansion of
fetal cardiac MSCs while retaining cardiovascular progeni-
tor phenotypes, with low gene-expression variability dur-
ing the course of culture.
Development of a Chemically Defined LN-Based Cell
Culture System
We have demonstrated that a combination of a basement
membrane (LN)-containing culture matrix (Geltrex) and
molecules that stimulate the canonical Wnt/b-catenin
signaling pathway enables propagation of cardiac MSCs
with cardiovascular progenitor characteristics. To obtain a
more defined matrix while maintaining successful propa-
gation of cardiac MSCs, we explored the possibility of uti-
lizing chemically defined LN-based matrices for expansion
and differentiation of these cells. Cultured pluripotent
stem cells and pluripotent cells of the inner cell mass of
the blastocyst express LN-511 and LN-521 (Rodin et al.,
2010; Domogatskaya et al., 2012). Since these LNs have
previously been demonstrated to support clonal expansion
of cultured embryonic stem cells (Rodin et al., 2014) and
the LN subunits a5 and g1 are also abundantly expressed
in human fetal hearts (Figure 4A), this suggests that
LN-511 and LN-521 may be suitable for derivation and
expansion of cardiac MSCs. LN-211, on the other hand,
might be linked to cardiomyocyte development and/or
function, as it has been shown to be defective in congenital
muscular dystrophic patients with cardiomyopathy (Fins-
terer et al., 2010), and a2 chains were also expressed in
the fetal heart (Figure 4A).610 Stem Cell Reports j Vol. 6 j 607–617 j April 12, 2016 j ª2016 The AuthoThe human fetal cardiac MSCs were cultured on human
recombinant LN-511and LN-521 using the sameWnt-con-
taining medium as described above. MSCs cultured on LN-
511 and LN-521 displayed a tendency toward increased
mRNA levels of ISL1 in comparison with cells cultured on
Geltrex. At the same time, TNNT2 levels remained low
(Figure 4B) and the expansion potential of the cells was un-
affected. In order to explore the capacity of LN-211 to sup-
port cardiomyocyte differentiation, cardiac MSCs derived
and expanded on LN-521were cultured on LN-211 in ame-
dium devoid of Wnt3a. After 2 weeks, the gene expression
of TNNT2 had increased 150 times, concomitantly with a
significant downregulation of KDR (Figure 4C). This indi-
cates that LN-211 has the potential to stimulate cardiac
commitment of cardiac MSCs at the gene-expression level.
In order to study the signaling pathways involved, we
blocked cell-laminin interactions with antibodies against
a-dystroglycan (a-DG) and b1-integrin, which are impor-
tant laminin receptors (Domogatskaya et al., 2012). This
caused a substantial reduction of TNNT2 expression (Fig-
ure 4D), which suggests that LN-211 interacts to a large
extent with the cardiac MSCs through these cellular
receptors.
Differentiation into Cardiomyocytes, Smooth Muscle
Cells, and Endothelial Cells
After 2 weeks of culture, the fetal cardiac MSCs expressed
cardiovascular progenitor markers, supporting their poten-
tial to differentiate into the different cell types of the heart.
In order to initiate cardiomyocyte differentiation, we
used a protocol previously developed for differentiation
of pluripotent stem cells (Lian et al., 2012, 2013). Expanded
cardiac MSCs from fetal hearts of 6, 8, and 9 weeks’ gesta-
tion were seeded on Matrigel and canonical Wnt signaling
was blocked using a defined serum-free medium to induce
cardiomyocyte differentiation. A portion of the cultured
cardiac MSCs derived from the 9-week heart differentiated
into spontaneously beating, troponin T+ (TnT+), striated
cardiomyocytes (Figures 5A and 5B and Movie S1) within
3 weeks, with no residual cardiomyocytes present before
initiation of differentiation (Figure 5C). The cells derived
from 6- to 8-week human fetal hearts did not differentiate
into TnT+ cardiomyocytes, despite similar expression of
ISL1, NKX2.5, PDGFR-a, SSEA-1, KDR, and c-KIT before
initiation of differentiation.
As shown in Figure 4C, we observed prominently
increased levels of TNNT2 in the fetal cardiac MSCs upon
culture on LN-211. Thus we replaced Matrigel, which is
not chemically defined and has a batch-to-batch vari-
ability, with LN-211 and used the same cardiomyocyte dif-
ferentiation protocol for theMSCs as described above (Lian
et al., 2012, 2013). The cells differentiated on LN-211 in
comparison with Matrigel showed equally increased levelsrs
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Figure 3. Characterization of Cultured Cardiac MSCs
(A) The gene-expression profile of key transcription factors related to mesodermal progenitors as well as markers of cardiovascular dif-
ferentiation and pluripotency was analyzed with microarray in cultured cardiac MSCs at day 15, 27, and 48. Log2 transformation of signals
is depicted as bar graphs.
(B) Immunofluorescence staining (green) of ISL1, TBX18 (arrows), and NKX2.5 after 3 weeks in culture.
(C) Flow cytometry analysis of cardiac MSCs from different human fetal hearts (gestational weeks 8 and 9, n = 6) gave a quantitative
assessment of the proportions of cells expressing KDR, c-KIT, and SSEA-1 (mean ± SD).
(D) Immunocytochemical staining of SSEA-1 (green) and PDGFR-a (green). Nuclei are stained with DAPI. In (B) and (D), scale bars
represent 50 mm.ofTNNT2 (Figure 5E) and also similar numbers of TnT+ cells
after differentiation (Figure 5F). Thus LN-211 proved to be
just as effective as Matrigel for supporting cardiomyocyte
differentiation of cardiac MSCs derived from the 9-week
heart.
Endothelial cell differentiation was induced in cardiac
MSCs by using a medium containing vascular endothelial
growth factor (VEGF). The substrates used were gelatin or
LNs present in the basal membranes of blood vessels (LN-
521 and LN-411) (Hallmann et al., 2005; Simon-Assmann
et al., 2011; Stenzel et al., 2011; Domogatskaya et al.,
2012). After 3 weeks in culture, a small proportion of the
cardiac MSCs expressed the endothelial marker CD31
(Figure 6, left panel) regardless of the substrate used,
showing that the chemically defined laminin combination
LN-521/LN-411 can support differentiation toward endo-
thelial cells (Figure 6, left panel).
The fetal cardiacMSCs expressed a-SMA prior to differen-
tiation (Figure 6, right panel), which has already been
described for other PDGFR-a+ cells (Chong et al., 2013).
After smooth muscle cell differentiation of the cardiac
MSCs, the a-SMA staining intensity did not seem to in-
crease but rather polarized into podosome-like structures
(Figure 6, right panel), which can be found in vascular
smooth muscle cells upon stimulation with exogenousStemPDGF-BB and TGF-b (Murphy and Courtneidge, 2011).
Our results demonstrate that human fetal cardiac MSCs
are multipotent, where different LN compositions can sup-
port their lineage specification.DISCUSSION
Herein, we describe that human fetal cardiac MSCs with
cardiac progenitor characteristics can be propagated by us-
ing a combination of a supplemented culture medium,
which stimulates the canonical Wnt/b-catenin pathway
and specific laminin isoforms as cell culture substrata,
without using any genetic manipulation or feeder cells.
During culture, the fetal cardiac MSCs stably expressed
early cardiovascular markers, and expanded rapidly
without changing their phenotype during the culturing
process. Excluding either Wnt3a or LN-based matrix from
the culture protocol affected either cell growth or the
gene expression of cardiac progenitor markers.
The origin of the different subpopulations of cardiac
MSCs has not been examined in this study. It has previ-
ously been reported that interstitial cells of both the atria
and ventricles, display a strong expression of PDGFR-a
(Chong et al., 2011, 2013). Chong et al. (2013) showedCell Reports j Vol. 6 j 607–617 j April 12, 2016 j ª2016 The Authors 611
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Figure 4. LN-Based Propagation and Dif-
ferentiation of Cardiac MSCs
(A) Immunohistochemical staining of lam-
inin chains a2, a5, and g1 (all red) in a
human fetal heart (gestational week 9).
Nuclei are stained with DAPI. Scale bars
represent 200 mm.
(B) Normalized mRNA levels ISL1 and TNNT2
from fetal cardiac MSCs cultured for 2 weeks
on Geltrex, LN-511 or LN-521 in medium
containing Wnt3a.
(C) Normalized mRNA levels of ISL1, KDR,
NKX2.5, and TNNT2 from cardiac MSCs
expanded for 2 weeks on LN-521 followed by
culture on LN-211 and Geltrex for 2 weeks in
medium devoid of Wnt3a. Data presented as
mean ± SD of three independent experi-
ments performed in quadruplicate. **p <
0.001.
(D) Normalized levels of TNNT2 expression
in cells cultured on Geltrex (control) or
LN-211 with or without blocking antibodies against a-DG and b1-integrins or corresponding isotype control antibodies. Data are
presented as means ± SD of three independent experiments performed in duplicate. *p = 0.05.that PDGFR-a+ cells isolated fromhuman fetal hearts of the
second trimester were multipotent and could be differenti-
ated into smooth muscle as well as endothelial cells, but
they did not differentiate into cardiomyocytes. In the pre-
sent study, the majority of the cultured cardiac MSCs
stained positive for PDGFR-a. Whether these cells possibly
originate from interstitial cells of the atria and ventricles re-
mains to be elucidated, but they displayed a similar capac-
ity to differentiate into endothelial cells and also cells with
polarized a-SMA expression akin to that of mature smooth
muscle cells. In contrast to the PDGFR-a+ cells previously
derived from second trimester hearts (Chong et al., 2013),
the fetal cardiac MSCs derived from a 9-week human heart
in the present study could be differentiated into spontane-
ously beating, striated TnT+ cardiomyocytes, although it
was only a small proportion of the cardiac MSCs that
demonstrated this ability. This restricted differentiation ca-
pacity might be related to the age of the fetal heart from
which the cardiac MSCs are derived, although in the pre-
sent study it could not be linked to age-related differences
in expression of markers known to characterize cardiovas-
cular progenitors like KDR, NKX2.5, c-KIT, and SSEA-1 (Ur-
banek et al., 2003; Beltrami et al., 2003; Bearzi et al., 2007;
Bruneau, 2002; Kwon et al., 2008; Durocher et al., 1996;
Jho et al., 2002; Millauer et al., 1993; Motoike et al., 2003).
c-KIT is a tyrosine kinase receptor that is expressed on
purported cardiovascular progenitors in the heart (Urbanek
et al., 2003; Beltrami et al., 2003; Bearzi et al., 2007; Bearzi
et al., 2009). The origin of these cells is still unknown.
Chong et al. (2013) have reported that a limited number
of PDGFR-a+ cells in the atria and ventricles of the fetal612 Stem Cell Reports j Vol. 6 j 607–617 j April 12, 2016 j ª2016 The Authohearts also express c-KIT, which is similar to our cardiac
MSCs, where approximately 2% expressed c-KIT. Although
subpopulations of the cardiac MSCs expressed c-KIT, we do
not know if these cells are similar to the previously
described cardiac progenitors in the adult heart (Urbanek
et al., 2003; Beltrami et al., 2003; Bearzi et al., 2007, 2009).
A small population of the fetal cardiac MSCs also ex-
presses SSEA-1, which has been reported to represent an
early marker of cardiovascular progenitors derived from
pluripotent stem cells (Blin et al., 2010). The existence of
a corresponding progenitor in the human fetal heart has
yet to be identified, and it remains to be further investi-
gatedwhether the SSEA-1-expressing cells identifiedwithin
the cardiac MSC population specifically have the potential
to develop into the different cell types of the heart.
Some of the cultured cardiac MSCs also stained positive
for the mesodermal progenitor marker TBX18 (Mommer-
steeg et al., 2010; Christoffels et al., 2006); future studies
need to be performed in order to address whether some
of the PDGFR-a+ and TBX18+ cells potentially share a devel-
opmental origin.
Interestingly, the use of specific LN molecules supported
lineage conversion of the cultured cardiac MSCs into cardi-
omyocytes and endothelial cells. By using LN-211 alone,
the main component of the basement membrane sur-
rounding adult cardiac and skeletal muscle fibers in situ
(Domogatskaya et al., 2012), the cardiac MSCs could be
differentiated into the cardiomyocyte lineage, with a 150
times increase of TNNT2 expression and a concomitant up-
regulation of NKX2.5. In addition, culture on LN-521/411,
which are present in the basal membranes of vesselsrs
ATnT
B
TnT
C
TnT
D
TnT
Be
for
e d
iff
LN
21
1
Ma
trig
el
0
50
100
150
n.s.
E
TN
N
T2
 m
R
N
A
Pla
sti
c
LN
 21
1
Ma
trig
el
0
20
40
60
80
100 * n.s.
F
Tn
T 
 c
el
ls
+
Figure 5. Cardiomyocyte Differentiation Potential of Human
Fetal Cardiac MSCs
(A) Upon exposure to cardiomyocyte differentiation medium, por-
tions of the cardiac MSCs differentiated into elongated, striated
TnT+ (green) cardiomyocytes. Scale bar represents 50 mm.
(B) A zoom-in of the box in (A) demonstrating the striations in the
cardiomyocytes.
(C) All cardiac MSCs stained negative for TnT prior to initiation of
the differentiation protocol. Scale bar represents 50 mm.
(D) Primary cardiomyocytes isolated from a human fetal heart were
used as a positive control. Nuclei are stained with DAPI (blue).
Scale bar represents 50 mm.
(E) Normalized mRNA levels of TNNT2 before and after differentia-
tion on Matrigel and LN-211.
(F) Numbers of TnT+ cells of human fetal cardiac MSCs differentiated
on plastic, LN-211, and Matrigel. Numbers of positive cells
are normalized against the total number of nuclei in the same
well multiplied by a factor of 100,000. Data are presented as
means ± SD of three independent experiments performed in trip-
licate. *p < 0.05.
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Figure 6. Differentiation into Endothelial and Smooth Muscle
Cells
The cardiac MSCs underwent differentiation into endothelial cells
(left panel) expressing CD31 (red) and smooth muscle cells (right
panel) expressing a-SMA (green). There was no CD31 expression
before differentiation, whereas the majority of the cardiac MSCs
expressed a-SMA in abundance before initiation of differentiation.
The intensity of the a-SMA staining did not increase as a result of
differentiation but rather appeared in a more polarized fashion
similar to what can be found in contractile, adult vascular smooth
muscle cells exposed to PDGF-BB and TGF-b1. Human aortic
endothelial cells (HAEC) and smooth muscle cells from a human
carotid artery (HCtSMC) were positive controls for endothelial cells
and smooth muscle cells, respectively. Nuclei are stained blue with
DAPI. Scale bars represent 50 mm.(Hallmann et al., 2005; Simon-Assmann et al., 2011; Sten-
zel et al., 2011; Domogatskaya et al., 2012), supported
differentiation toward endothelial cells expressing CD31.
In conclusion, we have developed a protocol for isolation
and large-scale expansion of human fetal cardiacMSCs thatStemexhibit properties of cardiac progenitor cells. These cells
can be used as a tool to investigate the regenerative capac-
ities of human fetal cardiac MSCs in a variety of contexts
related to chronic and acute myocardial injury, such as
hypoxia, fibrosis, and inflammation.EXPERIMENTAL PROCEDURES
Derivation and Expansion of Human Fetal
Cardiac MSCs
The fetal hearts were obtained from legal terminations of preg-
nancy after the donor’s informed consent and ethics approval
from the Regional Ethics Board in Stockholm.
The fetal heartswere pre-digested overnight at 4C in a 0.5mg/ml
Trypsin solution in Hank’s balanced salt solution (HBSS). TheMSC
fraction was prepared according to a modified version of theCell Reports j Vol. 6 j 607–617 j April 12, 2016 j ª2016 The Authors 613
protocol developed by Laugwitz et al. (2005). The pre-digested
heart was treated for 15minwith collagenase type II (Worthington
Biochemical) 160 U/ml in HBSS, at 37C under gentle stirring.
The supernatantwas centrifuged at 2203 g for 8min and the pellet
resuspended in low-glucose DMEM supplemented with 10%
fetal bovine serum (FBS) (PAA Laboratories), Mycozap (Lonza,
Switzerland) and GlutaMAX (Invitrogen). The collagenase diges-
tion was repeated until the tissue was completely dissociated. The
pooled cells were washed twice and resuspended in the same me-
dium as above. The cells were subsequently seeded on plastic and
cultured for 96 hr in order to recover the adherent fraction and
thereafter cryopreserved for later use. In order to propagate cardiac
MSCs, the adherent stromal cell fraction was seeded at a density of
30,000 cells/cm2 on cell culture plastic coated with a thin layer of
Geltrex (GibcoBRL) in DMEM/F12 supplemented with B27
(GibcoBRL), 2% FBS (PAA), MycoZap (Lonza), epidermal growth
factor (10 ng/ml) (R&D Systems) and 100 ng/ml recombinant hu-
man Wnt3a (R&D Systems). The cells were passaged every 2 days,
and at each passage, cells were harvested for immunocytochemical
analyses as described below.
In order to validate the cell culture protocol, different culturing
conditions were tested, where either Geltrex or Wnt3a was
excluded (gestational weeks 6.5–8, n = 3). After each passage, cells
were saved for further analyses and at the end of the experiment, at
2 and 3 weeks, the cells were harvested for immunocytochemistry,
PCR, and also microarray analyses.
Staining of Laminin Chains in Human Fetal Hearts
Human fetal hearts (gestational weeks 6–10, n = 3) were embedded
in OCT, snap-frozen and thereafter cryo-sectioned and stained for
anti-laminin a2 (MAB1922, clone 5H2,Millipore), anti-laminin a5
(MAB1924, clone 4C7, Millipore), or anti-laminin g1 (MAB1920,
clone 23 108, Millipore) and visualized by a secondary Alexa Fluor
568 goat anti-mouse antibody (A11031, Thermo Fischer Scienti-
fic). The cell nuclei were counterstained with DAPI.
Laminin-Based Derivation and Expansion of Human
Fetal Cardiac MSCs
To generate chemically definedmatrices for derivation and expan-
sion of human fetal cardiac MSCs (gestational weeks 6.5–8, n = 3),
the cells were grown in wells coated with LN-511, 521, or 211,
using the same culture medium as described above. The human
recombinant laminins were generated as previously described
(Kortesmaa et al., 2000; Doi et al., 2002; Rodin et al., 2014) or pur-
chased from BioLamina AB (batches 80,051, 80,050, and 80,042,
respectively).
Differentiation of Cardiac MSCs
For cardiomyocyte differentiation in vitro we used a modified pro-
tocol developed for humanpluripotent stemcells (Lian et al., 2012,
2013), where the cardiac MSCs were cultured on Matrigel, LN-211
or plastic. Cardiac MSCs derived from fetal hearts of different ages
(gestational week 6, 8, and 9, n = 3) were used. After 3 weeks, cells
were fixed in 4% phosphate-buffered formalin and stained with a
mouse monoclonal antibody against human troponin T (TnT)
(ab8295, clone 1C11, Abcam) and visualized with an Alexa Fluor
488-conjugated rabbit anti-mouse secondary antibody (A11059,614 Stem Cell Reports j Vol. 6 j 607–617 j April 12, 2016 j ª2016 The AuthoThermo Fisher Scientific). RNA extraction and qRT-PCR for
TNNT2 and GAPDH were performed as described in Supplemental
Experimental Procedures. For imaging of calcium signaling
dynamics, cells were labeled with the Ca2+-sensitive fluorescence
indicator Fluo-4/AM (10 mM; Molecular Probes, Thermo Fischer
Scientific) according to the manufacturers’ protocol.
For differentiation toward vascular smooth muscle cells, the
cardiac MSCs were seeded on gelatin-coated plastic, and cultured
for 18 days in a defined medium supplemented with PDGF-BB
(10ng/ml) and TGF-b1 (2 ng/ml) (PeproTech), according to amodi-
fied protocol previously described by Cheung et al. (2014). Cells
were passaged 1:4 once per week into new gelatin-coated wells.
Subsequently, the cells were fixed and stained with a mouse anti-
human a-smooth muscle actin primary antibody (A2547, clone
1A4; Sigma-Aldrich) and visualized by a rabbit anti-mouse Alexa
Fluor 488-conjugated secondary antibody (Thermo Fischer Scienti-
fic). The experiment was performed in duplicate using cells from
four different hearts of gestational age 8 and 9 weeks.
For endothelial differentiation, cardiac MSCs were seeded in
culture wells pre-coated overnight with a 1:4 mixture of LN-521/
411 (5 mg/cm2) or gelatin (0.1%) and cultured for 21 days in
EGM-2medium (Lonza) with VEGF (50 ng/ml) from R&D Systems
(Liu et al., 2007). Subsequently, the cells were fixed and stained
with a monoclonal mouse anti-human CD31 antibody (M0823,
clone JC70A). Stained cells were visualized using an Alexa Fluor
568-conjugated goat anti-mouse secondary antibody (Thermo
Fischer Scientific). The experiment was performed in duplicate us-
ing cells from five different hearts of gestational age 8 and 9 weeks.Statistics
Real-time qRT-PCR data are presented as means ± SD. Student’s
t test (two-tailed, two samples, unequal variances) was used for
statistical analysis. For analysis of TnT+ cells after differentiation,
the Kruskal-Wallis test with Bonferroni correction was used. p <
0.05 was considered to indicate statistical significance.
Full details on the methods used are presented in the Supple-
mental Experimental Procedures.
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